VM

Vrinda Mohandas Kamath

Director DIN 02952646
DIN 02952646 First appointment Jul 2015
Unlock full profile Investments Β· shareholding Β· contact details
Past companies 2 historical roles
Total affiliations 2 Since Jul 2015
Shareholding value β€’β€’β€’β€’ Premium profile

About Vrinda Mohandas Kamath

Data last updated:

Vrinda Mohandas Kamath was a Director at Tajucco Pharma Private Limited (from 2016) and Director at Manipal Pharma Private Limited (from 2015).

DIN 02952646
First Appointment 03 Jul 2015
Oldest Company Age 16 yrs

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Tajucco Pharma Private Limited U85190KA2010PTC052930
Director31 Jul 20162010₹40.4 Lakh (FY 2019)Strike Off
Manipal Pharma Private Limited U85100KA2010PTC052866
Director03 Jul 20152010Strike Off

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Tajucco Pharma Private Limited
Manipal Pharma Private Limited
Premium access

Shareholding and investment profile for Vrinda Mohandas Kamath

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Vrinda Mohandas Kamath

Vrinda Mohandas Kamath was first appointed on 03 Jul 2015 as Director at Manipal Pharma Private Limited. The most recent appointment on record is 31 Jul 2016 at Tajucco Pharma Private Limited.

Vrinda Mohandas Kamath held 2 earlier board appointments: Tajucco Pharma Private Limited (Director, from 31 Jul 2016); Manipal Pharma Private Limited (Director, from 03 Jul 2015).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available